Insider Transactions in Q3 2024 at Stoke Therapeutics, Inc. (STOK)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2024
|
Skorpios Trust > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,937,500
-17.87%
|
$27,125,000
$14.05 P/Share
|
|
Sep 03
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-47.37%
|
$150,000
$15.17 P/Share
|
|
Sep 03
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.47%
|
$0
$0.6 P/Share
|
|
Aug 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-80.1%
|
$140,000
$14.58 P/Share
|
|
Aug 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.47%
|
$0
$0.6 P/Share
|
|
Jul 02
2024
|
Huw M. Nash Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,500
-99.34%
|
$32,500
$13.5 P/Share
|
|
Jul 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-80.1%
|
$130,000
$13.75 P/Share
|
|
Jul 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.47%
|
$0
$0.6 P/Share
|